[
    "Z)-4-chloro-\u03b2-[2-(methoxymethyloxy)ethyl]-\u03b2-styrylsulfonyl]piperazine\n(355 mg) was dissolved in ethanol\n(3 ml), followed by the addition of saturated ethanol hydrochloride\n(6 ml). The resulting mixture was stirred at\nroom temperature for 1 hour. After the reaction mixture\nwas concentrated under reduced pressure, the residue was\nprovided for the similar reaction as in Example 4, whereby\nthe title compound (285 mg, 65%) was obtained.\n<sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) \u03b4: 2.58(2H,t,J=6.6Hz), 3.06(4H,br s),\n3.15-3.60(4H,br), 3.68(2H,t,J=6.6Hz), 7.24(1H,s),\n7.38(2H,d,J=8.6Hz), 7.40(2H,d,J=8.6Hz), 7.47-7.57(3H,m),\n8.02-8.10(2H,m), 8.14(2H,d,J=8.3Hz), 8.74(1H,d,J=4.4Hz).\nMS (FAB) m/z: 512 (M+H)<sup>+</sup>.</p>[Example 134] 1-[(E)-4-chloro-\u03b2-(2-hydroxyethan-1-yl)-\u03b2-styrylsulfonyl]-4-[4-(pyridin-2-yl)benzoyl]piperazine\nhydrochlorideIn a similar manner to Example 133 except for the use\nof 4-tert-butoxycarbonyl-1-[(E)-4-chloro-\u03b2-[2-(methoxymethyloxy)ethyl]-\u03b2-styrylsulfonyl]piperazine\nas the\nraw material, the title compound was obtained.\n<sup>1</sup>H-NMR (DMSO-d<sub>6</sub>) \u03b4: 2.74(2H,t,J=7.3Hz), 3.27(4H,br s),\n3.37-3.85(6H,m), 7.45(1H,s), 7.50-7.60(5H,m),\n7.68(2H,d,J=8.3Hz), 8.06-8.17(4H,m), 8.75(1H,d,J=4.9Hz). \nMS (FAB) m/z: 512 (M+H)<sup>+</sup>.\nElementary analysis for C<sub>26</sub>H<sub>26</sub>ClN<sub>3</sub>O<sub>4</sub>S\u00b71.1HCl\u00b70.8H<sub>2</sub>OCalculatedC, 55.12;H, 5.11;N, 7.42;Cl, 13.14;S, 5.66.FoundC, 55.22;H, 5.21;N, 7.20;Cl, 12.97;S, 5.66.</p>[Test 1] Measurement of Ki value against FXaIn a 96-well microtiter plate, 5 \u00b5l of a sample solution,\n5 \u00b5l of purified water, 40 \u00b5l of a 100 mM tris -\n200mM sodium chloride - 0.2% BSA (pH: 7.4) buffer and 10 \u00b5l\nof 0.05 U/ml human FXa (product of Enzyme Research, dissolved\nin and diluted with a measuring buffer) were poured,\nfollowed by the addition of 40 \u00b5l of S2222 (product of\nChromogenix, final concentration: 75, 150, 300 and 600 \u00b5M).\nAn increase in the absorbance at 405 nm was measured at\nroom temperature for 15 minutes. From a reciprocal of the\nreaction rate and concentration of the inhibitor, four primary\nregression equations (Y= aX + b) were found (Dixon\nPlot). The median of six values available by solving simultaneous\nequations was designated as a Ki value.</p>The Ki values of the compounds obtained in Examples\n91 and 93 against FXa were 6.6 nM and 10.9 nM, respectively.</p>[Test 2] Measurement of Ki value against thrombinIn a 96-well microtiter plate, 5 \u00b5l of a sample solution, \n5 \u00b5l of purified water, 40 \u00b5l of a 100 mM tris -\n200mM sodium chloride -0.2% BSA (pH: 7.4) buffer and 10 \u00b5l\nof 5 U/ml human thrombin (product of Sigma Chemical, dissolved\nin and diluted with a measuring buffer) were poured\nin portions, followed by the addition of 40 \u00b5l of S2226\n(product of Chromogenix, final concentration: 50, 100, 200\nand 400 \u00b5M). An increase in the absorbance at 405 nm was\nmeasured at room temperature for 15 minutes. From a reciprocal\nof the reaction rate and concentration of the inhibitor,\nfour primary regression equations (Y= aX + b) were\nfound (Dixon Plot). The median of six values available by\nsolving simultaneous equations was designated as a Ki\nvalue.</p>The Ki values of the compounds obtained in Examples\n91 and 93 against thrombin were 0.4 \u00b5M and 3.3 \u00b5M, respectively.</p>[Test 3] Measurement of FXa inhibitory action (IC<sub>50</sub>)1) Reaction rate methodIn a 96-well microtiter plate, 10 \u00b5l of a sample solution,\n40 \u00b5l of a 100 mM tris - 200mM sodium chloride -0.2%\nBSA (pH: 7.4) buffer and 10 \u00b5l of 0.05 U/ml human FXa\n(\"Cosmobio-ERL HFXa-1011\", dissolved in and diluted with a\nmeasuring buffer) were poured in portions, followed by the\naddition of 40 ml of S2222 (product of Chromogenix). An\nincrease (mOD/min) in the absorbance at 405 nm was measured \nat room temperature. From the below-described equation, an\ninhibitory ratio % of each sample was determined. On a\nlogarithmic probability paper, the final concentration of\nthe sample and inhibitory ratio % were plotted along the\nabscissa and the ordinate, respectively, whereby a 50% inhibitory\nconcentration (IC<sub>50</sub>) was determined.\nInhibitory ratio (%) = (1 - OD of sample \u00f7 OD of control)\nx 100</p>The compound of Example 92 showed a FXa 50% inhibitory\nconcentration of 7.8 nM.</p>2) End point methodA sample solution (100 \u00b5l), 280 \u00b5l of a 100 mM tris -\n200mM sodium chloride (pH 7.4) buffer and 100 \u00b5l of a 1mM\nS2222 (Chromogenix Corp.) solution were mixed and heated at\n37\u00b0C. To the resulting mixture, 20 \u00b5l of 0.625 U/ml human\nFXa (\"Cosmobio-ERL HFXa-1011\", dissolved in and diluted\nwith a measuring buffer) were added, followed by heating at\n37\u00b0C for 15 minutes. To the resulting m"
]